Support: 888-992-3836 Home NewsWire Subscriptions
InvestorsHub Logo
Login/Register
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NYSE
  6. GSK plc (GSK)

  7. GSK plc (GSK) News

GSK

GSK plc

33.80
0.20 (0.6%)
Upgrade to Real-Time
Company Name Stock Ticker Symbol Market Type
GSK plc GSK NYSE Depository Receipt
  Price Change Change Percent Stock Price Last Traded
Upgrade Icon
0.20 0.6% 33.80 20:00:00
Open Price Low Price High Price Close Price Prev Close
33.52 33.33 34.00 33.80 33.60
more quote information »

Recent News

Date Time Source Heading
6/01/20237:35IHNWFeaturedNew Break Announces Closing of $500,700 Non-Brokered Flow-Through Financing
6/01/202311:56EDGARReport of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16..
6/01/202308:00BWGSK Announces the COiMMUNITY Initiative to Help Achieve..
5/30/202314:33EDGARSpecialized Disclosure Report (sd)
5/16/202317:01BWBELLUS Santé inc. convoque une assemblée extraordinaire des..
5/15/202312:53EDGARReport of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16..
5/15/202312:49EDGARReport of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16..
5/12/202311:53EDGARReport of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16..
5/12/202306:50EDGARReport of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16..
5/12/202306:44EDGARReport of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16..
5/12/202306:39EDGARReport of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16..
5/12/202306:01EDGARReport of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16..
5/12/202303:24DJNGSK Welcomes Canadian Court Decision to Dismiss Proposed..
5/12/202302:47DJNGSK Sells Haleon Shares at 335p Each, Raising GBP804 Million
5/11/202312:25DJNGSK to Sell Its 2.5% Stake in Haleon
5/11/202312:14GLOBESpringWorks Therapeutics Announces Clinical Data..
5/04/202310:31EDGARReport of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16..
5/03/202317:36VWHaleon – Strong Start, But Pfizer To Exit
5/03/202313:43DJNGSK's RSV Vaccine Approved for Older Adults by FDA
5/03/202313:37BWUS FDA Approves GSK’s AREXVY, the World’s First Respiratory..
4/28/202312:56EDGARReport of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16..
4/27/202306:51EDGARReport of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16..
4/26/202312:02EDGARReport of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16..
4/26/202305:43DJNTrending: GSK Backs 2023 Guidance After 1Q Beat
4/26/202303:05DJNGSK 1Q Profit, Sales Beat Expectations But Fell On-Year;..
4/25/202306:35EDGARReport of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16..
4/20/202310:54EDGARReport of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16..
4/19/202311:10EDGARReport of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16..
4/18/202312:11BWGSK reaches agreement to acquire late-stage..
4/18/202310:42DJNBellus Health Toronto-Listed Shares Double on GSK Takeover
4/18/202307:55EDGARReport of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16..
4/18/202306:30DJNTrending: GSK Buys Bellus Health for About $2 Billion
4/18/202306:24DJNBellus Health Shares Soar Premarket on Takeover by GSK
4/18/202302:48DJNGSK to Acquire Canadian BELLUS Health for Around $2 Billion
4/17/202306:34EDGARReport of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16..
4/17/202302:51DJNGSK Reports Positive Phase 3 Data for UTI Oral Antibiotic
4/03/202308:11EDGARReport of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16..
3/30/202310:43DJNScynexis Shares Jump 60% After Licensing Deal With GSK
3/28/202308:01EDGARReport of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16..
3/27/202318:21PRNUSPhase III RUBY clinical trial demonstrates potential of..
3/27/202308:52EDGARReport of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16..
3/24/202308:30EDGARReport of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16..
3/24/202306:52DJNGSK Disagrees With Court Ruling to Allow Plaintiff-Expert..
3/20/202311:42EDGARReport of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16..
3/14/202318:51DJNADRs End Higher; Credit Suisse, GSK Trade Actively
3/14/202312:00BWGSK and Earvin “Magic” Johnson Partner to Raise Awareness of..
3/14/202307:05EDGARReport of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16..
3/14/202303:53DJNGSK Reports Positive Phase 3 Data For Meningococcal Vaccine..
3/14/202303:47DJNGSK's Nucala Accepted for New Drug Application Review in..
3/13/202311:40EDGARReport of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16..
3/10/202312:21EDGARPost-effective Amendment to Registration Statement (pos Am)